Published in Gut on August 01, 1979
Comparison between cimetidine and Caved-S in the treatment of gastric ulceration, and subsequent maintenance therapy. Gut (1982) 1.05
Gastric ulcer healing with tripotassium dicitrato bismuthate and subsequent relapse. Gut (1982) 0.98
Factors influencing the healing rate of gastric ulcer in hospitalised subjects. Gut (1984) 0.84
Medical management of peptic ulcer. Postgrad Med J (1984) 0.82
The effect of cimetidine on the maintenance of healing of gastric ulceration. Postgrad Med J (1984) 0.80
Cimetidine and placebo in the treatment of benign gastric ulcer: a multicenter double blind study. Gastroenterology (1978) 1.75
Cimetidine in the treatment of gastric ulcer: review and commentary. Gastroenterology (1978) 1.30
Gastric and duodenal ulcer healing under placebo treatment. Gastroenterology (1977) 1.23
Increased nitric oxide synthesis in ulcerative colitis. Lancet (1993) 3.81
Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet (1993) 3.19
Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome. Lancet (1982) 3.04
Exclusive elemental diet impacts on the gastrointestinal microbiota and improves symptoms in patients with chronic pouchitis. J Crohns Colitis (2012) 2.00
Clinical testing of gliadin fractions in coeliac patients. Clin Sci (Lond) (1984) 1.93
Abnormal colonic fermentation in irritable bowel syndrome. Lancet (1998) 1.91
Wheat peptide challenge in coeliac disease. Lancet (1994) 1.88
Crohn's disease: maintenance of remission by diet. Lancet (1985) 1.70
Characterization of the humoral immune response to Klebsiella species in inflammatory bowel disease and ankylosing spondylitis. Br J Rheumatol (1998) 1.69
Pitfalls in diagnosing coeliac disease. J Clin Pathol (1994) 1.55
Antacid maintenance therapy in the prevention of duodenal ulcer relapse. Gut (1988) 1.54
Pre-pouch ileitis: a disease of the ileum in ulcerative colitis after restorative proctocolectomy. Colorectal Dis (2006) 1.52
An arteriographic study of mesenteric arterial disease. I. Large vessel changes. Gut (1967) 1.52
Endomysial antibody production is not related to histological damage after in vitro gluten challenge. Eur J Gastroenterol Hepatol (2000) 1.46
Decreased salivary epidermal growth factor in rheumatoid disease: a possible mechanism for increased susceptibility to gastric ulceration. BMJ (1990) 1.46
1-Alpha-hydroxycholecalciferol as a substitute for the kidney hormone 1,25-dihydroxycholecalciferol in chronic renal failure. Lancet (1973) 1.43
Extraintestinal manifestations of ulcerative colitis following restorative proctocolectomy. Eur J Gastroenterol Hepatol (1999) 1.42
The role of faecal Candida albicans in the pathogenesis of food-intolerant irritable bowel syndrome. Postgrad Med J (1992) 1.41
Family linkage study of the T-cell receptor genes in coeliac disease. Ital J Gastroenterol Hepatol (1999) 1.41
Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody. Gut (1995) 1.40
Anxiety and irritable bowel syndrome. Lancet (1996) 1.39
Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Dig Dis Sci (2002) 1.32
Persistence of mucosal abnormality in ulcerative colitis. Gut (1966) 1.32
Diet in the management of Crohn's disease. Hum Nutr Appl Nutr (1984) 1.32
Stimulation of lymphocytes from patients with coeliac disease by a subfraction of gluten. Lancet (1976) 1.31
Cimetidine in the prevention of gastric ulcer relapse. Postgrad Med J (1979) 1.29
Raised pro-inflammatory cytokines interleukin 6 and tumour necrosis factor alpha in coeliac disease mucosa detected by immunohistochemistry. Gut (1994) 1.28
Secretion of gliadin antibody by coeliac jejunal mucosal biopsies cultured in vitro. Clin Exp Immunol (1986) 1.27
Accuracy of serology for the diagnosis of Helicobacter pylori infection--a comparison of eight kits. J Clin Pathol (1996) 1.27
Neurologic presentation of decompression sickness and air embolism in sport divers. Neurology (1985) 1.26
Identification and characterization of the glucose transporter of the blood-brain barrier by cytochalasin B binding and immunological reactivity. Proc Natl Acad Sci U S A (1984) 1.25
Serum antibodies (measured by MRSPAH) to alcohol-soluble gliadins in adult coeliac patients. J Immunol Methods (1981) 1.24
Detection of interferon gamma mRNA in the mucosa of patients with coeliac disease by in situ hybridisation. Gut (1994) 1.24
Clinical testing of bread made from nullisomic 6A wheats in coeliac patients. Lancet (1980) 1.22
Chronic lymphocytic gastritis and protein losing gastropathy. Gut (1989) 1.20
Are all gliadins toxic in coeliac disease? An in vitro study of alpha, beta, gamma, and w gliadins. Scand J Gastroenterol (1984) 1.20
Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge. Gut (1995) 1.18
Evaluation of the effectiveness of a specialist nurse in the management of inflammatory bowel disease (IBD). Eur J Gastroenterol Hepatol (2000) 1.17
The physiological expression of inducible nitric oxide synthase (iNOS) in the human colon. J Clin Pathol (2001) 1.16
Differential upregulation of intercellular adhesion molecule-1 in coeliac disease. Clin Exp Immunol (1990) 1.16
The effect of gluten on HLA-DR in the small intestinal epithelium of patients with coeliac disease. Clin Exp Immunol (1986) 1.16
Review article: restorative proctocolectomy, indications, management of complications and follow-up--a guide for gastroenterologists. Aliment Pharmacol Ther (2008) 1.11
Exocrine and endocrine pancreatic function in diabetes mellitus and chronic pancreatitis. Gut (1966) 1.11
A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics. Br J Nutr (2002) 1.09
In vitro toxicity of gluten peptides in coeliac disease assessed by organ culture. Scand J Gastroenterol (1995) 1.09
Expression of c-myc in non-malignant and pre-malignant gastrointestinal disorders. J Pathol (1987) 1.09
Review article: faecal transplantation therapy for gastrointestinal disease. Aliment Pharmacol Ther (2011) 1.09
Coeliac disease: in vivo toxicity of the putative immunodominant epitope. Gut (2003) 1.08
Epidermal growth factor stimulates synthesis and secretion of mucus glycoproteins in human gastric mucosa. Clin Sci (Lond) (1990) 1.07
Technique for suction biopsy of the rectal mucosa. Gut (1970) 1.07
Analysis and clinical effects of gluten in coeliac disease. Eur J Gastroenterol Hepatol (2001) 1.06
Highly selective vagotomy and pyloric dilatation for duodenal ulcer with stenosis. Br J Surg (1981) 1.04
A radioimmunoassay for alpha- and beta-gliadins. Clin Sci (Lond) (1983) 1.04
Plasma insulin in pancreatic disease. Gut (1970) 1.04
Review article: coeliac disease and its management. Aliment Pharmacol Ther (1999) 1.04
HLA-DRB, -DQA, and -DQB polymorphism in celiac disease and enteropathy-associated T-cell lymphoma. Common features and additional risk factors for malignancy. Hum Immunol (1995) 1.03
Early biochemical responses of the small intestine of coeliac patients to wheat gluten. Gut (1989) 1.03
HLA-DR, DP and DQ expression in the small intestine of patients with coeliac disease. Clin Exp Immunol (1987) 1.02
Timing of infiltration of T lymphocytes induced by gluten into the small intestine in coeliac disease. J Clin Pathol (1987) 1.01
Effects of interferon-gamma and tumour necrosis factor-alpha on epithelial HLA class-II expression on jejunal mucosal biopsy specimens cultured in vitro. Scand J Gastroenterol (1992) 1.00
Cimetidine and gastric ulcer healing. Br Med J (1977) 1.00
Investigation of the putative immunodominant T cell epitopes in coeliac disease. Gut (2003) 0.99
Evaluation of indium scintigraphy in patients with active inflammatory bowel disease. Gut (1984) 0.98
Characteristics of human IgA and IgM genes used by plasma cells in the salivary gland resemble those used in duodenum but not those used in the spleen. J Immunol (2000) 0.98
Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease. Gut (2001) 0.98
Specific ouabain binding to brain microvessels and choroid plexus. J Cereb Blood Flow Metab (1985) 0.97
Celiac disease: strongly heritable, oligogenic, but genetically complex. Mol Genet Metab (2000) 0.97
HLA class II alleles associated with celiac disease susceptibility in a southern European population. Tissue Antigens (1992) 0.97
Expression of tumour necrosis factor-alpha, interleukin-6, and interleukin-2 mRNA in the jejunum of patients with coeliac disease. Scand J Gastroenterol (1995) 0.97
Long-chain triglycerides reduce the efficacy of enteral feeds in patients with active Crohn's disease. Clin Nutr (1995) 0.96
Small intestinal injury in a neonatal rat model of giardiasis is strain dependent. Gastroenterology (1995) 0.96
A randomised controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease. Gut (2001) 0.96
Colonoscopic hydrostatic balloon dilatation of Crohn's strictures. J Clin Gastroenterol (2001) 0.95
Celiac disease among Ashkenazi Jews from Israel. A study of the HLA class II alleles and their associations with disease susceptibility. Hum Immunol (1993) 0.93
Confirmation of nitric oxide synthesis in active ulcerative colitis by infra-red diode laser spectroscopy. Eur J Gastroenterol Hepatol (1997) 0.93
Sub-class of IgG in allergic disease. I. IgG sub-class antibodies in immediate and non-immediate food allergy. Clin Allergy (1986) 0.92
Translocation of gliadin into HLA-DR antigen containing lysosomes in coeliac disease enterocytes. Gut (1995) 0.92
Systemic Weber-Christian disease: a case report with lipoprotein profile and immunological evaluation. Br J Dermatol (1980) 0.91
Increased gastric juice epidermal growth factor after non-steroidal anti-inflammatory drug ingestion. Gut (1994) 0.91
Helicobacter pylori increases gastric antral juxtamucosal pH. Dig Dis Sci (1993) 0.90
Does Crohn's disease have a mycobacterial basis? BMJ (1993) 0.90
A 3-month, double-blind, controlled trial of feeding with sucrose polyester in human volunteers. Br J Nutr (1998) 0.89
A genome-wide family-based linkage study of coeliac disease. Ann Hum Genet (2000) 0.89
A solid-phase radioimmunoassay for measurement of circulating antibody titres to wheat gliadin and its subfractions in patients with adult coeliac disease. J Immunol Methods (1983) 0.89
A review of associations between Crohn's disease and consumption of sugars. Eur J Clin Nutr (1998) 0.88
Irritable bowel syndrome: is the search for lactose intolerance justified? Eur J Gastroenterol Hepatol (2001) 0.88
Nitric oxide affects mammalian distal colonic smooth muscle by tonic neural inhibition. Br J Pharmacol (1993) 0.88
A non-toxic analogue of a coeliac-activating gliadin peptide: a basis for immunomodulation? Aliment Pharmacol Ther (1999) 0.88
Instability in the faecal flora of a patient suffering from food-related irritable bowel syndrome. J Med Microbiol (1987) 0.87
Binding of gluten-derived peptides to the HLA-DQ2 (alpha1*0501, beta1*0201) molecule, assessed in a cellular assay. Clin Exp Immunol (1998) 0.87
Etiology of pouchitis. Inflamm Bowel Dis (2011) 0.87
Western immunoblotting of cereal proteins with monoclonal antibodies to wheat gliadin to investigate coeliac disease. Int Arch Allergy Appl Immunol (1988) 0.87